Ā | Vi-DT | Vi-PS |
---|---|---|
Gender | ||
Males (%) | 45 | 40 |
Females (%) | 55 | 60 |
Mean age (years) | 25.26 | 25.18 |
Seroconversionāā„ā4 times (%) at 28 days compared to baseline | 100% | 95.96% |
Pre-vaccination GMT (IU/mL) | 0.0226103 | 0.0048849 |
28 days post-vaccination GMT (IU/mL) | 263.9313 | 51.72027 |